NANO — Nanobiotix SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapValue Trap

Annual balance sheet for Nanobiotix SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	119	83.9	41.4	75.3	49.7
Net Total Accounts Receivable
Net Total Receivables	3.88	6.93	7.99	9.49	8.54
Prepaid Expenses
Total Other Current Assets
Total Current Assets	125	93.1	52.4	87.3	61.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.26	8.19	7.12	6.25	5.54
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	134	102	59.8	93.9	67.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19	36.8	37.9	49.9	58.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	63.6	75	86.8	95.7	133
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	70.5	26.8	-27	-1.84	-65.7
Total Liabilities & Shareholders' Equity	134	102	59.8	93.9	67.4
Total Common Shares Outstanding